icon-folder.gif   Conference Reports for NATAP  
 
  Reported by Jules Levin
ACG Annual Scientific Meeting
Philadelphia, PA, October 20, 2014

Back grey_arrow_rt.gif
 
 
 
Results From the Phase 2 PEARL-I Study: Interferon-free Regimens of ABT-450/r + ABT-267 With or Without Ribavirin in Patients With HCV Genotype 4 Infection
 
 
  Reported by Jules Levin
 
Presented at the American College of Gastroenterology-79th Annual Scientific Meeting, October 17-22, 2014, Philadelphia, Pennsylvania, United States
 
Christophe Hezode1, Patrick Marcellin2, Stanislas Pol3, Tarek Hassanein4, Katarzyna Fleischer-Stepniewska5, Tianli Wang6, Sandra S Lovell6, Tami Pilot-Mati as6, Regis A Vilchez6 1Assistance Publique Hopitaux de Paris, Paris, France; 2H˘pital Beaujon Inserm Crb3-U 773-Service Hepatologie, Clichy, France; 3Groupe Hospitalier Cochin-Saint Vincent de Paul, Paris, France; 4Southern California Liver Centers and Southern California Research Center, Coronado, California, United States; 5EMC Instytut Medyczny Spolka Akcyjna, Wroclaw, Poland; 6AbbVie Inc., North Chicago, Illinois, United States

ACG1.gif

ACG2.gif

ACG3.gif

ACG4.gif

ACG5.gif

ACG6.gif

ACG7.gif

ACG8.gif